K.E. Livingston
Pharmacologic evidence for a putative conserved allosteric site on opioid receptors
Livingston, K.E.; Stanczyk, M.A.; Burford, N.T.; Alt, A.; Canals, M.; Traynor, J.R.
Authors
M.A. Stanczyk
N.T. Burford
A. Alt
MERITXELL CANALS M.CANALS@NOTTINGHAM.AC.UK
Professor of Cellular Pharmacology
J.R. Traynor
Abstract
Allosteric modulators of G protein-coupled receptors, including opioid receptors, have been proposed as possible therapeutic agents with enhanced selectivity. BMS-986122 is a positive allosteric modulator (PAM) of the μ-opioid receptor (μ-OR). BMS-986187 is a structurally distinct PAM for the δ-opioid receptor (δ-OR) that has been reported to exhibit 100-fold selectivity in promoting δ-OR over μ-OR agonism. We used ligand binding and second-messenger assays to show that BMS-986187 is an effective PAM at the μ-OR and at the κ-opioid receptor (κ-OR), but it is ineffective at the nociceptin receptor. The affinity of BMS-986187 for δ-ORs and κ-ORs is approximately 20- to 30-fold higher than for μ-ORs, determined using an allosteric ternary complex model. Moreover, we provide evidence, using a silent allosteric modulator as an allosteric antagonist, that BMS-986187 and BMS-986122 bind to a similar region on all three traditional opioid receptor types (μ-OR, δ-OR, and κ-OR). In contrast to the dogma surrounding allosteric modulators, the results indicate a possible conserved allosteric binding site across the opioid receptor family that can accommodate structurally diverse molecules. These findings have implications for the development of selective allosteric modulators. Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.
Citation
Livingston, K., Stanczyk, M., Burford, N., Alt, A., Canals, M., & Traynor, J. (2018). Pharmacologic evidence for a putative conserved allosteric site on opioid receptors. Molecular Pharmacology, 93(2), 157-167. https://doi.org/10.1124/mol.117.109561
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 27, 2017 |
Online Publication Date | Jan 12, 2018 |
Publication Date | Feb 1, 2018 |
Deposit Date | Jan 13, 2020 |
Print ISSN | 0026-895X |
Publisher | American Society for Pharmacology and Experimental Therapeutics |
Peer Reviewed | Peer Reviewed |
Volume | 93 |
Issue | 2 |
Pages | 157-167 |
DOI | https://doi.org/10.1124/mol.117.109561 |
Keywords | bms 986122; bms 986187; delta opiate receptor; kappa opiate receptor; mu opiate receptor; nociceptin receptor; opiate agonist; opiate antagonist; opiate receptor; unclassified drug; allosteric site; animal cell; Article; binding affinity; binding site; co |
Public URL | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041169717&doi=10.1124%2fmol.117.109561&partnerID=40&md5=ba991a91eb1bcfce83371990e736efde |
Publisher URL | http://molpharm.aspetjournals.org/content/93/2/157/tab-article-info |
You might also like
Opioid pharmacology under the microscope
(2020)
Journal Article